Related Experiment Video
Updated: Apr 19, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
MTA1 promotes cell proliferation via DNA damage repair in epithelial ovarian cancer
1Department of Laboratory Medicine, Tenth People's Hospital of Tongji University, Shanghai, China.
Abstract:
We examined whether metastasis-associated gene 1 (MTA1) promotes cell proliferation via DNA damage repair in ovarian cancer. MTA1 was successfully down-regulated using small interfering RNA in the epithelial ovarian cancer cell lines SKOV-3 and OVCAR-3. Cell growth was evaluated through MTT and colony formation assays. Fluorescence-activated cell sorting analysis was used to evaluate the distribution of cells in the cell cycle, and cytotoxicity assays were performed to study cell sensitivity to cisplatin. A neutral comet assay was used to measure levels of ionizing radiation-induced DNA damage in SKOV-3 cells, and Western blot analyses were carried out to examine the expression of key proteins involved in DNA damage repair pathways. MTA1 knockdown markedly inhibited cell growth and led to S phase cell cycle arrest. In addition, MTA1 depletion conferred sensitivity of ovarian cancer cells to cisplatin. Moreover, MTA1 depletion increased the level of ionizing radiation-induced DNA damage and caused irreparable damage, which was illustrated by a remarkable increase and persistent existence of a comet tail as well as protein expression levels of γH2AX, pRPA, and pChk1, all of which play critical roles in DNA repair. Thus, MTA1 promotes the proliferation of epithelial ovarian cancer cells by enhancing DNA repair.
Insights
Metastasis-associated gene 1 (MTA1) drives ovarian cancer cell growth by enhancing DNA repair mechanisms. Inhibiting MTA1 reduces proliferation and increases sensitivity to chemotherapy, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Metastasis-associated gene 1 (MTA1) is implicated in cancer progression.
- The role of MTA1 in ovarian cancer cell proliferation and DNA repair remains unclear.
Purpose of the Study:
- To investigate if MTA1 promotes ovarian cancer cell proliferation by enhancing DNA damage repair.
- To assess the impact of MTA1 downregulation on ovarian cancer cell growth, cell cycle, and sensitivity to cisplatin.
Main Methods:
- Small interfering RNA (siRNA) was used to downregulate MTA1 in SKOV-3 and OVCAR-3 ovarian cancer cell lines.
- Cell proliferation was assessed using MTT and colony formation assays.
- Cell cycle distribution, cisplatin sensitivity, DNA damage (comet assay), and DNA repair protein expression (Western blot) were analyzed.
Main Results:
- MTA1 knockdown significantly inhibited ovarian cancer cell growth and induced S phase cell cycle arrest.
- Downregulation of MTA1 increased ovarian cancer cell sensitivity to cisplatin treatment.
- MTA1 depletion led to increased and persistent ionizing radiation-induced DNA damage, evidenced by comet assay and elevated levels of DNA repair proteins (γH2AX, pRPA, pChk1).
Conclusions:
- MTA1 promotes epithelial ovarian cancer cell proliferation by enhancing DNA repair pathways.
- Targeting MTA1 may represent a viable strategy to overcome cisplatin resistance and inhibit ovarian cancer progression.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Abnormal Proliferation
Mitogens and the Cell Cycle
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

